← All trials
NCT07115056
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2025
- Primary completion
- Nov 1, 2027
- Completion date
- Nov 1, 2027
- First posted
- Aug 11, 2025
- Last posted
- Aug 11, 2025
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Campbell ClinicLead sponsor
- Campbell ClinicSponsor investigator
- Duke UniversityCollaborator
- University of PittsburghCollaborator
- Endeavor HealthCollaborator
- University of CincinnatiCollaborator
- Washington University in St. LouisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.